+关注
定位心海的锚
暂无个人介绍
IP属地:浙江
12
关注
0
粉丝
3
主题
0
勋章
主贴
热门
定位心海的锚
2021-06-24
本来以为平台上的东西都会比较贵,而且派送路程上的因素比较多。怕东西不新鲜。因为打新接触到每日优鲜平台,看着东西和日常也差不多,还方便很多,尝试一下。期待体验!
$每日优鲜(MF)$
定位心海的锚
2021-06-01
回发行就不错了。还20.29
高盛首予兆科眼科-B(06622.HK)「买入」评级 目标价20.29元
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3576884508574632,"uuid":"3576884508574632","gmtCreate":1613791433714,"gmtModify":1622516428665,"name":"定位心海的锚","pinyin":"dwxhdmdingweixinhaidemao","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/f4724c34b859ffe87fa6c33f3807576b","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":12,"tweetSize":3,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":3,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"浙江","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":128337377,"gmtCreate":1624501209499,"gmtModify":1624501209499,"author":{"id":"3576884508574632","authorId":"3576884508574632","name":"定位心海的锚","avatar":"https://static.tigerbbs.com/f4724c34b859ffe87fa6c33f3807576b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"本来以为平台上的东西都会比较贵,而且派送路程上的因素比较多。怕东西不新鲜。因为打新接触到每日优鲜平台,看着东西和日常也差不多,还方便很多,尝试一下。期待体验!<a href=\"https://laohu8.com/S/MF\">$每日优鲜(MF)$</a>","listText":"本来以为平台上的东西都会比较贵,而且派送路程上的因素比较多。怕东西不新鲜。因为打新接触到每日优鲜平台,看着东西和日常也差不多,还方便很多,尝试一下。期待体验!<a href=\"https://laohu8.com/S/MF\">$每日优鲜(MF)$</a>","text":"本来以为平台上的东西都会比较贵,而且派送路程上的因素比较多。怕东西不新鲜。因为打新接触到每日优鲜平台,看着东西和日常也差不多,还方便很多,尝试一下。期待体验!$每日优鲜(MF)$","images":[{"img":"https://static.tigerbbs.com/138d792b015f5f4ffa5535f84a38ab88","width":"1080","height":"2400"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/128337377","isVote":1,"tweetType":1,"viewCount":1279,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":119943210,"gmtCreate":1622515372530,"gmtModify":1622515372530,"author":{"id":"3576884508574632","authorId":"3576884508574632","name":"定位心海的锚","avatar":"https://static.tigerbbs.com/f4724c34b859ffe87fa6c33f3807576b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"回发行就不错了。还20.29","listText":"回发行就不错了。还20.29","text":"回发行就不错了。还20.29","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/119943210","repostId":"2140457860","repostType":2,"repost":{"id":"2140457860","pubTimestamp":1622512131,"share":"https://www.laohu8.com/m/news/2140457860?lang=&edition=full","pubTime":"2021-06-01 09:48","market":"us","language":"zh","title":"高盛首予兆科眼科-B(06622.HK)「买入」评级 目标价20.29元","url":"https://stock-news.laohu8.com/highlight/detail?id=2140457860","media":"AAFN","summary":"高盛发表报告表示,看好兆科眼科-B 业务增长前景,主因内地眼科药物市场的巨大增长潜力、公司的创新和多目标管道辅以仿制药以及其作为全球眼科资产进入内地渠道的潜力等因素,首予其「买入」评级 及目标价20.29元。(sw/k)~阿思达克财经新闻网址: www.aastocks.com","content":"<html><body><p><a href=\"https://laohu8.com/S/GS\">高盛</a>发表报告表示,看好<a href=\"https://laohu8.com/S/06622\">兆科眼科-B</a> 业务增长前景,主因内地眼科药物市场的巨大增长潜力、公司的创新和多目标管道辅以仿制药以及其作为全球眼科资产进入内地渠道的潜力等因素,首予其「买入」评级 及目标价20.29元。(sw/k)~阿思达克财经新闻网址: www.aastocks.com</p></body></html>","source":"aastocks","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>高盛首予兆科眼科-B(06622.HK)「买入」评级 目标价20.29元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n高盛首予兆科眼科-B(06622.HK)「买入」评级 目标价20.29元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-01 09:48 北京时间 <a href=http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1102412&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0><strong>AAFN</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>高盛发表报告表示,看好兆科眼科-B 业务增长前景,主因内地眼科药物市场的巨大增长潜力、公司的创新和多目标管道辅以仿制药以及其作为全球眼科资产进入内地渠道的潜力等因素,首予其「买入」评级 及目标价20.29元。(sw/k)~阿思达克财经新闻网址: www.aastocks.com</p>\n\n<a href=\"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1102412&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/4b6684517506a0b0f4c4c5a1c4889261","relate_stocks":{"06622":"兆科眼科-B"},"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1102412&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","is_english":false,"share_image_url":"https://static.laohu8.com/51f6b9126f36f92bbf92982596066e5a","article_id":"2140457860","content_text":"高盛发表报告表示,看好兆科眼科-B 业务增长前景,主因内地眼科药物市场的巨大增长潜力、公司的创新和多目标管道辅以仿制药以及其作为全球眼科资产进入内地渠道的潜力等因素,首予其「买入」评级 及目标价20.29元。(sw/k)~阿思达克财经新闻网址: www.aastocks.com","news_type":1},"isVote":1,"tweetType":1,"viewCount":736,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":128337377,"gmtCreate":1624501209499,"gmtModify":1624501209499,"author":{"id":"3576884508574632","authorId":"3576884508574632","name":"定位心海的锚","avatar":"https://static.tigerbbs.com/f4724c34b859ffe87fa6c33f3807576b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"本来以为平台上的东西都会比较贵,而且派送路程上的因素比较多。怕东西不新鲜。因为打新接触到每日优鲜平台,看着东西和日常也差不多,还方便很多,尝试一下。期待体验!<a href=\"https://laohu8.com/S/MF\">$每日优鲜(MF)$</a>","listText":"本来以为平台上的东西都会比较贵,而且派送路程上的因素比较多。怕东西不新鲜。因为打新接触到每日优鲜平台,看着东西和日常也差不多,还方便很多,尝试一下。期待体验!<a href=\"https://laohu8.com/S/MF\">$每日优鲜(MF)$</a>","text":"本来以为平台上的东西都会比较贵,而且派送路程上的因素比较多。怕东西不新鲜。因为打新接触到每日优鲜平台,看着东西和日常也差不多,还方便很多,尝试一下。期待体验!$每日优鲜(MF)$","images":[{"img":"https://static.tigerbbs.com/138d792b015f5f4ffa5535f84a38ab88","width":"1080","height":"2400"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/128337377","isVote":1,"tweetType":1,"viewCount":1279,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":119943210,"gmtCreate":1622515372530,"gmtModify":1622515372530,"author":{"id":"3576884508574632","authorId":"3576884508574632","name":"定位心海的锚","avatar":"https://static.tigerbbs.com/f4724c34b859ffe87fa6c33f3807576b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"回发行就不错了。还20.29","listText":"回发行就不错了。还20.29","text":"回发行就不错了。还20.29","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/119943210","repostId":"2140457860","repostType":2,"repost":{"id":"2140457860","pubTimestamp":1622512131,"share":"https://www.laohu8.com/m/news/2140457860?lang=&edition=full","pubTime":"2021-06-01 09:48","market":"us","language":"zh","title":"高盛首予兆科眼科-B(06622.HK)「买入」评级 目标价20.29元","url":"https://stock-news.laohu8.com/highlight/detail?id=2140457860","media":"AAFN","summary":"高盛发表报告表示,看好兆科眼科-B 业务增长前景,主因内地眼科药物市场的巨大增长潜力、公司的创新和多目标管道辅以仿制药以及其作为全球眼科资产进入内地渠道的潜力等因素,首予其「买入」评级 及目标价20.29元。(sw/k)~阿思达克财经新闻网址: www.aastocks.com","content":"<html><body><p><a href=\"https://laohu8.com/S/GS\">高盛</a>发表报告表示,看好<a href=\"https://laohu8.com/S/06622\">兆科眼科-B</a> 业务增长前景,主因内地眼科药物市场的巨大增长潜力、公司的创新和多目标管道辅以仿制药以及其作为全球眼科资产进入内地渠道的潜力等因素,首予其「买入」评级 及目标价20.29元。(sw/k)~阿思达克财经新闻网址: www.aastocks.com</p></body></html>","source":"aastocks","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>高盛首予兆科眼科-B(06622.HK)「买入」评级 目标价20.29元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n高盛首予兆科眼科-B(06622.HK)「买入」评级 目标价20.29元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-01 09:48 北京时间 <a href=http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1102412&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0><strong>AAFN</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>高盛发表报告表示,看好兆科眼科-B 业务增长前景,主因内地眼科药物市场的巨大增长潜力、公司的创新和多目标管道辅以仿制药以及其作为全球眼科资产进入内地渠道的潜力等因素,首予其「买入」评级 及目标价20.29元。(sw/k)~阿思达克财经新闻网址: www.aastocks.com</p>\n\n<a href=\"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1102412&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/4b6684517506a0b0f4c4c5a1c4889261","relate_stocks":{"06622":"兆科眼科-B"},"source_url":"http://www.aastocks.com/apps/data/iphone/news/newscontent.aspx?newsid=NOW.1102412&style=5&chgstyle=1&categoryid=stock&width=320&market_id=hk&fontary=3&platform=iPhone&language=sc&isfirstreq=1&sourceid=aafn&datatype=0","is_english":false,"share_image_url":"https://static.laohu8.com/51f6b9126f36f92bbf92982596066e5a","article_id":"2140457860","content_text":"高盛发表报告表示,看好兆科眼科-B 业务增长前景,主因内地眼科药物市场的巨大增长潜力、公司的创新和多目标管道辅以仿制药以及其作为全球眼科资产进入内地渠道的潜力等因素,首予其「买入」评级 及目标价20.29元。(sw/k)~阿思达克财经新闻网址: www.aastocks.com","news_type":1},"isVote":1,"tweetType":1,"viewCount":736,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}